‘Spider-Man’ stays at No. 1 in 4th weekend

Spider-Man’s box office dominance continued in its fourth weekend in theaters, adding another $33 million in ticket sales according to studio estimates on Sunday

The glamorous spies of “The 355” were no competition for the movie theater’s reigning webslinger.

Spider-Man’s box office dominance continued in its fourth weekend in theaters, adding another $33 million, according to studio estimates on Sunday. With $668.8 million in North American ticket sales to date, “Spider-Man: No Way Home” is now the sixth highest grossing release of all time domestically. Globally, with $1.5 billion and counting, it ranks in eighth place.

The only major new film this weekend was Universal’s “The 355,” an original spy thriller starring Jessica Chastain Lupita Nyong’o, Diane Kruger and Penelope Cruz which debuted in third place with $4.8 million from 3,145 North American theaters. Directed by Simon Kingberg, reviews for the film about a global coalition of female spies have been less than stellar: It holds a 27% on Rotten Tomatoes.

But the audience scores have been more enthusiastic, especially from women, and about a third of the attendees this weekend were over 45 — a demographic that has not gone out to movie theaters much during the pandemic. With a holiday weekend coming up, Jim Orr, Universal s head of domestic distribution, said, “We think we'll have a nice runway.”

“The 355” came in behind the animated “Sing 2,” also distributed by Universal, which grossed an estimated $12 million in its third weekend in theaters, bringing its global total to $190.8 million.

With omicron cases surging, Hollywood has entered 2022 cautiously. January's biggest new release, the Spider-Man spinoff “Morbius," was recently pushed to April.

“There’s a bit of uncertainty in the marketplace because of the omicron variant,” said Paul Dergarabedian, Comscore s senior media analyst. “Studios want to protect their crown jewels and give them the greatest shot at success in movie theaters. A delay like that shows they’re not giving up on the theaters. But studios are very aware of this marketplace and what the challenges might be.”

And while January is now destined to be quiet at the box office, Dergarabedian said that Spider-Man has been a “beacon of hope" for the industry.

"It shows that audiences want to go back to the movie theater," he said. “We could end up having a really strong box office year, but only time will tell.”

Estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Comscore. Final domestic figures will be released Monday.

1. “Spider-Man: No Way Home,” $33 million.

2. “Sing 2,” $12 million.

3. “The 355,” $4.8 million.

4. “The King's Man,” $3.4 million.

5. “American Underdog,” $2.4 million.

6. “The Matrix Resurrections,” $1.9 million.

7. “West Side Story,” $1.4 million.

8. “Ghostbusters: Afterlife,” $1.1 million.

9. “Licorice Pizza,” $1 million.

10. “House of Gucci,” $632,348.

___

Follow AP Film Writer Lindsey Bahr on Twitter at: http://twitter.com/ldbahr

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in